Effect of prostacyclin on microvascular pressures in a patient with pulmonary veno-occlusive disease.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 7497799.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Continuous-infusion prostacyclin improves symptom scores and decreases mortality in patients with primary pulmonary hypertension, but use of prostacyclin in patients with pulmonary veno-occlusive disease may precipitate pulmonary edema. A patient with pulmonary veno-occlusive disease received a graduated intravenous infusion of prostacyclin and pulmonary capillary pressures were calculated during prostacyclin dose ranging. Calculated capillary pressure increased with low-dose prostacyclin (< or = 6 ng/kg/min) but decreased with higher doses. These data suggest that the post-capillary pulmonary venules in our patient had reversible vasomotor tone, but required a higher dose of prostacyclin to vasodilate than did the precapillary arterioles.
Medical subject headings
- Blood Pressure
- Epoprostenol
- Platelet Aggregation Inhibitors
- Pulmonary Circulation
- Pulmonary Veno-Occlusive Disease
- Vasodilator Agents